This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Lisata Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Harri Jarvelainen: Innovator in Pharmaceutical Compositions
Introduction
Harri Jarvelainen is a notable inventor based in Tampere, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel cyclic peptides. His work focuses on creating innovative solutions for treating solid tumor cancers.
Latest Patents
Harri Jarvelainen holds 1 patent for his invention titled "Pharmaceutical compositions comprising novel cyclic peptides." This patent encompasses the synthetic processes, compositions, properties, and applications of these peptides, highlighting their stability and pharmacokinetic profiles.
Career Highlights
Jarvelainen is associated with Lisata Therapeutics, Inc., where he applies his expertise in pharmaceutical development. His work is pivotal in advancing therapeutic options for cancer treatment, showcasing his commitment to improving patient outcomes.
Collaborations
Due to space constraints, the collaborations section will be omitted.
Conclusion
Harri Jarvelainen's innovative work in pharmaceutical compositions exemplifies the impact of novel cyclic peptides in cancer treatment. His contributions are vital to the ongoing advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile